As with PTSD, people develop acute stress disorder after exposure to traumatic events. The key difference in the diagnostic ...
The following is a summary of “Impact of impaired renal function on kinetics of high-sensitive cardiac troponin following ...
Meloxicam and rizatriptan can eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severity.
Medicare's mandatory TEAM demonstration for surgical care requires coordination between hospitals and post-acute care ...
Acute pulmonary embolism is rare during childhood and adolescence. The high pulmonary embolism-related fatality among ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
Men with prostate cancer are living longer than ever, and our goal is to reduce the risk of late toxicities, such as difficulty urinating or rectal bleeding, that can impact a patient’s quality of ...
The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback